Skip to main content

Table 2 Baseline characteristics of the study population

From: Long-term outcomes after penile prosthesis placement for the Management of Erectile Dysfunction: a single-Centre experience

Characteristic Study cohort (N = 130)
Age (years), median [IQR] 62.5 [58–69]
ASA score, median [IQR] 2 [1–2]
IIEF-5 score, median [IQR] 6 [5–7]
Time between ED and PP implant (months), median [IQR] 38 [24–72]
Primary cause of ED, n (%)
 Diabetes 35 (26.9)
 Radical prostatectomy 59 (45.4)
 Priapism/penile trauma 6 (4.6)
 Spinal cord injury 2 (1.5)
 Peyronie’s disease 8 (6.2)
 Iatrogenic 4 (3.1)
 Others 16 (12.3)
Previous ED treatment, n (%)
 PDE5-I 69 (53.1)
 Intracavernous injection 122 (93.8)
 Penile prothesis 5 (3.8)
 Vacuum 9 (6.9)
PP type, n (%)
 AMS 700 76 (58.5)
 Coloplast Titan 54 (41.5)
Surgical approach, n (%)
 Peno-scrotal 96 (73.8)
 Infra-pubic 34 (26.2)
Follow-up (years), median [IQR] 6.3 ± [4–9.4]
  1. ASA American Society of Anaesthesiologists, IIEF International Index of Erectile Function, PP penile prosthesis, ED erectile dysfunction, IQR interquartile range